US 12264345
PH20 polypeptide variants, formulations and uses thereof
granted A61KA61K38/00A61K38/28
Quick answer
US patent 12264345 (PH20 polypeptide variants, formulations and uses thereof) held by HALOZYME, INC. expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- HALOZYME, INC.
- Grant date
- Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/00, A61K38/28, A61K38/47, A61K45/06